KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Accounts Payables (2016 - 2025)

Humana (HUM) has disclosed Accounts Payables for 15 consecutive years, with $5.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Accounts Payables changed N/A to $5.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.7 billion, a N/A change, with the full-year FY2025 number at $5.7 billion, changed N/A from a year prior.
  • Accounts Payables was $5.7 billion for Q4 2025 at Humana, up from $5.5 billion in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $8.1 billion in Q2 2023 to a low of $4.5 billion in Q4 2021.
  • A 4-year average of $5.9 billion and a median of $5.6 billion in 2025 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: fell 20.68% in 2021, then skyrocketed 40.28% in 2023.
  • Humana's Accounts Payables stood at $4.5 billion in 2021, then increased by 16.17% to $5.2 billion in 2022, then surged by 45.09% to $7.6 billion in 2023, then decreased by 24.78% to $5.7 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Accounts Payables are $5.7 billion (Q4 2025), $5.5 billion (Q3 2025), and $5.6 billion (Q2 2025).